Altre lingue PT Kalbe Farma Tbk.

Azioni

KLBF

ID1000125107

Prezzo di chiusura INDONESIA S.E. Altri mercati azionari 00:00:00 24/06/2024			Variaz. 5gg	Var. 1 gen.
1.550 ^IDR	-1,27%		-0,96%	-3,73%

17/05	PT KALBE FARMA TBK. : Nomura mantiene la raccomandazione Buy	ZM
30/04	PT Kalbe Farma Tbk. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

PT Kalbe Farma Tbk : Kalbe to Buy Back Shares of Rp1 trillion	29/05
PT Kalbe Farma Tbk : Company Update - Q1 2024 Unaudited Results (02-May-2024)	02/05
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23/10/23
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	13/09/23
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	01/09/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	17/07/23
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	08/07/23
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	04/05/23
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	02/05/23
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	28/04/23
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23
PT Kalbe Farma Tbk : THE INAUGURATION OF THE KALBE UBAYA HANBANG-BIO LABORATORY PILOT PLANT, SUPPORTING THE INDEPENDENCE OF NATIONAL INGREDIENTS	02/03/23
Progen Co. Ltd. announced that it has received IDR 155.72 billion in funding from PT Kalbe Farma Tbk.	02/01/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2022	31/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue PT Kalbe Farma Tbk.

Azioni

KLBF

ID1000125107

Altre lingue

Filtri